Psychopharmacology of atypical antipsychotics and clinical outcomes in elderly patients

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 13, 1999, Pages 5-9

  Kumar, Vinod ^a   Brecher, Martin ^b  

^a Florida Institute of Neurosciences and Clinical Research   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

DEMENTIA; DRUG EFFICACY; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0032774403     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Kumar V. Use of atypical antipsychotic agents in geriatric patients: a review. Int J Geriatr Psychopharmacol 1997;1:15-23
2. Pickar D. Prospects for pharmacotherapy of schizophrenia. Lancet 1995; 345:557-561
3. Schotte A, Janssen PFM, Gommeren W, et al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 1996;124:57-73
4. Bymaster FP, Calligaro DO, Falcone JF, et al. Radioceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 1996; 14:87-96
5. Sedvall G, Farde L. Chemical brain anatomy in schizophrenia. Lancet 1995;346:743-749
6. Goldberg RJ, Goldberg J. Risperidone for dementia-related disturbed behavior in nursing home patients: a clinical experience. Int Psychogeriatr 1997;9:65-68
7. Aronson SM, Lingam V, Stack M. Risperidone in the treatment of elderly psychiatric patients. Presented at the 9th annual meeting of the American Association for Geriatric Psychiatry; Feb 16-19, 1996; Tucson, Ariz
8. Chengappa KNR, Baker RW, Kreinbrook SB, et al. Clozapine use in female geriatric patients with psychoses. J Geriatr Psychiatry Neurol 1994;7: 131-134
9. Rabey JM, Treves TA, Neufeld MY, et al. Low-dose clozapine treatment of levodopa-induced mental disturbance in Parkinson's disease. Neurology 1995;45:432-434
10. Frankenburg FR, Kalunian D. Clozapine in the elderly. J Geriatr Psychiatry Neurol 1994;7:129-132
11. Salzman C, Vaccaro B, Lieff J, et al. Clozapine in older patients with psychosis and behavioral disruption. Am J Geriatr Psychiatry 1995;3:26-33
12. Katz IR, Jeste DV, Mintzer JE, et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. J Clin Psychiatry 1999;60:107-115
13. Reisberg B, Borenstein J, Salob SP, et al. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987;48 (5, suppl):9-15
14. Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull 1988;24:653-659
15. Madhusoodanan S, Brecher M, Brenner R, et al. Risperidone in the treatment of elderly patients with psychotic disorders. Am J Geriatr Psychiatry. In press
16. Kay SR, Fiszbein A, Opler L. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276
17. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976
18. Chouinard G, Ross-Chouinard A, Annable L, et al. The Extrapyramidal Symptom Rating Scale [abstract]. Can J Neurol Sci 1980;7:233